RICCIO, ANNA MARIA
 Distribuzione geografica
Continente #
EU - Europa 9.498
AS - Asia 370
SA - Sud America 50
NA - Nord America 33
AF - Africa 6
Totale 9.957
Nazione #
IT - Italia 9.488
SG - Singapore 166
CN - Cina 96
VN - Vietnam 82
BR - Brasile 30
US - Stati Uniti d'America 23
AR - Argentina 13
MX - Messico 9
ID - Indonesia 8
HK - Hong Kong 7
BD - Bangladesh 4
CO - Colombia 3
EC - Ecuador 3
NL - Olanda 3
IQ - Iraq 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AL - Albania 1
BW - Botswana 1
DE - Germania 1
DZ - Algeria 1
IN - India 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
PA - Panama 1
PY - Paraguay 1
SE - Svezia 1
UZ - Uzbekistan 1
Totale 9.957
Città #
Genova 5.689
Genoa 2.347
Rapallo 847
Vado Ligure 573
Singapore 71
Beijing 27
Hanoi 24
Ho Chi Minh City 24
Bordighera 21
Ashburn 11
Hong Kong 7
Biên Hòa 6
Mexico City 6
São Paulo 5
Tianjin 5
Da Nang 4
Haiphong 3
Jakarta 3
Buenos Aires 2
Dallas 2
Dhaka 2
Guangzhou 2
Hải Dương 2
Los Angeles 2
New York 2
Recife 2
Thái Bình 2
Verona 2
Acaraú 1
Agawam 1
Ambato 1
Amman 1
Amsterdam 1
Asunción 1
Bab Ezzouar 1
Baghdad 1
Barra do Piraí 1
Belo Horizonte 1
Bonito 1
Braço do Norte 1
Buon Ma Thuot 1
Bình Dương 1
Can Tho 1
Carmo do Cajuru 1
Cartagena 1
Chisinau 1
Cibitung 1
Corrientes 1
Culiacán 1
Divinópolis 1
Durban 1
Figueira 1
Formosa 1
Frankfurt am Main 1
General Las Heras 1
Jandira 1
Jundiaí 1
Karbala 1
Khimki 1
Lanús 1
Las Balsas 1
Lomas de Zamora 1
Maceió 1
Maitengwe 1
Marrakesh 1
Medan 1
Medford 1
Milan 1
Montería 1
Mumbai 1
Nairobi 1
Nanyang 1
Newark 1
Nha Trang 1
Ninh Bình 1
Ohrid 1
Orangeburg 1
Ourinhos 1
Panama City 1
Pato Branco 1
Paulínia 1
Porto Alegre 1
Portoviejo 1
Queimada Nova 1
Querétaro 1
Quilmes 1
Reconquista 1
Rio das Ostras 1
Samara 1
Samarinda 1
San Fernando 1
San Juan 1
Santa María 1
Santiago del Estero 1
Shijiazhuang 1
Stockholm 1
Sumaré 1
Suzano 1
Sóc Trăng 1
Tashkent 1
Totale 9.765
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 281
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 194
Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. 191
Galectin-3: An early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months 186
Molecular phenotyping and biomarker development: Are we on our way towards targeted therapy for severe asthma? 177
CD40 on adult human airway epithelial cells: expression and proinflammatory effects 166
B7.1 costimulatory molecule is expressed on thyroid follicular cells in Hashimoto's thyroiditis, but not in Graves' disease. 165
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 165
In Vitro Reduction of Interleukin-8 Response to Enterococcus faecalis by Escherichia coli Strains Isolated from the Same Polymicrobial Urines 163
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 162
Inhibition of adhesion molecules by budesonide on a human epithelial cell line (lung carcinoma) 161
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 159
Nasal cytology: Methodology with application to clinical practice and research 156
Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation. 155
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. 155
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations. 155
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 155
Proteomics of bronchial biopsies: galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients. 154
Clara cell 16 protein in COPD sputum: A marker of small airways damage? 153
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 152
Biomarkers and severe asthma: a critical appraisal. 152
New insights into airway remodelling in asthma and its possible modulation. 151
Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients. 150
Biomarker discovery in asthma and COPD by proteomic approaches 148
Assessment of extravascular lung water by quantitative ultrasound and CT in isolated bovine lung 147
Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis 144
Serum cytotoxic T lymphocyte-associated antigen 4 in hymenoptera venom allergy and its modulation by specific immunotherapy 144
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 143
Molecular diagnosis and precision medicine in allergy management 141
Salbutamol: how does it enter smooth muscle cells? 140
Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects. 138
Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study. 138
Antiallergic activity of topical lodoxamide on in vivo and in vitro models. 138
Preliminary evidence for 'aberrant' expression of the leukocyte integrin LFA-1 (CD11a/CD18) on conjunctival epithelial cells of patients with mite allergy 138
Allergenius, an expert system for the interpretation of allergen microarray results 138
A model of allergen-driven human airway contraction:beta2 pathway dysfunction without cytokine involvement. 135
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation 134
Importance of fibroblasts-myofibroblasts in asthma-induced airway remodeling. 133
Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity. 133
Cytokine pattern in allergic and non-allergic chronic rhinosinusitis in asthmatic children 132
Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro 132
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum ctla-4 and IL-10. 131
Seasonal rhinitis and azelastine: long- or short-term treatment? 125
Intercellular adhesion molecule-1 on cultured human epithelial cell lines: influence of proinflammatory cytokines 125
Medical treatment reverses cytokine pattern in allergic and nonallergic chronic rhinosinusitis in asthmatic children 123
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 123
“ Immunologia dell’apparato Respiratorio e metodiche di studio “ Cap 8 120
On the functional consequences of bronchial basement membrane thickening 119
Local nasal immunotherapy: experimental evidences and general considerations. 118
In situ hybridization analysis of ICAM-1 (CD54) mRNA on conjunctival epithelium during allergic inflammation 118
Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts 117
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life 111
Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial. 109
Intercellular adhesion molecules: Clinical Perspectives 108
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study 108
null 106
One year of mepolizumab. Efficacy and safety in real-life in Italy 100
IL-13 and idiopathic pulmonary fibrosis: Possible links and new therapeutic strategies 99
Randomised controlled trial of local heart allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis 96
Effect of statins on fibroblasts from human nasal polyps and turbinates. 94
Serum intercellular adhesion molecule-1 and long-term response to IFN-alpha2b therapy in chronic hepatitis C 94
Duration of antiinflammatory and symptomatic effects after suspension of intranasal corticosteroid in persistent allergic rhinitis. 93
Different intrathyroid expression of intercellular adhesion molecule-1 (ICAM-1) in Hashimoto's thyroiditis and Graves' disease: analysis at mRNA level and association with b7.1 costimulatory molecule-Comment 91
Montelukast effects on inflammation in allergic rhinitis: a double blind placebo controlled pilot study. 89
Small airway morphology and lung funtion in the transition from normality to chronic airway obstruction 87
CD40 and VCAM1 expression on conjunctival epithelium cells in dry eye patients 86
Nasal endoscopy in asthmatic children: assessment of rhinosinusitis and adenoiditis incidence, correlation with cytology and microbiology 86
The relationship between clinical efficacy of specific immunotherapy and serum intercellular adhesion molecule-1 levels. 82
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders 80
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 79
VCAM-1 in conjunctival inflammation. 76
Quick Olfactory Sniffin’ Sticks Test (Q-Sticks) for the detection of smell disorders in COVID-19 patients 75
Preseasonal specific immunotherapy with modified Phleum pratense allergenic extracts: tolerability and effects. 75
Peripheral airways involvement in the pathogenesis of COPD. 74
Severe asthma: One disease and multiple definitions 66
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD 63
Immune induction of airway remodeling 58
Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study 55
Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. 54
Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps 45
Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy 28
Moderate asthma: burden, mechanisms and therapeutic perspectives 26
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis 10
Totale 10.076
Categoria #
all - tutte 32.192
article - articoli 31.102
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.090
Totale 64.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021391 0 0 0 0 0 35 10 63 48 113 53 69
2021/2022922 19 50 93 95 30 67 56 232 51 94 26 109
2022/20231.011 99 86 9 84 157 160 28 64 169 47 93 15
2023/2024473 29 79 10 67 47 78 44 23 26 4 20 46
2024/20251.522 33 106 57 84 163 166 133 283 65 85 156 191
2025/20261.297 336 99 260 179 385 38 0 0 0 0 0 0
Totale 10.076